COMPOSITION COMPRISING LIPOSOME-ENTRAPPED DOXORUBICIN AND METHODS OF ADMINISTRATION
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 30, 2011
app pub date -
Jun 3, 2009
filing date -
Jun 3, 2008
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Patients suffering from cancer, such as ovarian cancer, may be treated by administering an effective combined amount of a liposomal-entrappeddoxorubicin, an alkylating antineoplastic agent, and a vascular endothelial growth factor inhibitor. In one embodiment, patients suffering from ovarian cancer are treated by administering an effective combined amount of the liposome-entrapped doxorubicin product DOXIL, carboplatin and bevacizumab.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully